Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

BACKGROUND: Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) are related to several acquired demyelinating syndromes in adults, but the therapeutic approach is currently unclear. We aimed to describe the response to different therapeutic strategies in adult patients with relapsing MOG-Ab-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobo-Calvo, Alvaro, Sepúlveda, María, Rollot, Fabien, Armangué, Thais, Ruiz, Anne, Maillart, Elisabeth, Papeix, Caroline, Audoin, Bertrand, Zephir, Helene, Biotti, Damien, Ciron, Jonathan, Durand-Dubief, Francoise, Collongues, Nicolas, Ayrignac, Xavier, Labauge, Pierre, Thouvenot, Eric, Bourre, Bertrand, Montcuquet, Alexis, Cohen, Mikael, Deschamps, Romain, Solà-Valls, Nuria, Llufriu, Sara, De Seze, Jerome, Blanco, Yolanda, Vukusic, Sandra, Saiz, Albert, Marignier, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607517/
https://www.ncbi.nlm.nih.gov/pubmed/31266527
http://dx.doi.org/10.1186/s12974-019-1525-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607517/
https://www.ncbi.nlm.nih.gov/pubmed/31266527
http://dx.doi.org/10.1186/s12974-019-1525-1

Ejemplares similares